Healthcare & Pharmaceuticals

Healthcare and pharmaceutical companies in India navigate a regulatory architecture that spans the Central Drugs Standard Control Organisation, the National Pharmaceutical Pricing Authority, the Medical Devices Rules 2017, clinical trial regulations, and the broader framework of the Drugs and Cosmetics Act. Each segment of the sector carries distinct compliance obligations — drug manufacturers face CDSCO licensing and GMP requirements, hospitals deal with Clinical Establishment Act and medical council obligations, and medical device companies must navigate market authorisation and post-market surveillance.

Patent strategy is central to pharmaceutical business. India's section 3(d) patentability requirements, compulsory licensing provisions, pre-grant and post-grant opposition procedures, and the interface between patents and drug pricing through NPPA all require specialist guidance. Corpus Juris Legal's IP practice handles pharmaceutical patent prosecution, freedom-to-operate analysis, and infringement litigation — with experience in both the patent office and the Delhi High Court's IP Division.

Healthcare M&A presents unique due diligence demands. Regulatory licences are typically non-transferable, meaning deal structure must account for fresh licensing in the target's name post-acquisition. Medical professionals' employment agreements, consent and liability documentation, and hospital information system data governance all add complexity. As healthcare companies digitise their patient data infrastructure, DPDP Act obligations — including health data processing rules and breach notification requirements — are becoming a central compliance priority. Corpus Juris Legal advises across the healthcare legal spectrum.